Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation - Concepedia

Concepedia

Publication | Open Access

Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation

DOI Full Paper Access

249

Citations

20

References

2017

Year

Sophie Glatt, Dominique Baeten, Terry Baker, Meryn Griffiths, Lucian Ionescu, Alastair D. G. Lawson, Ash Maroof, Ruth Oliver, Serghei Popa, Foteini Strimenopoulou,

Annals of the Rheumatic Diseases

Abstract

NCT02141763; Results.

References

	Year	Citations

Page 1